WhichRecall
Class IIReported 2025-03-26

Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-445-20.

Recalled by Mylan Institutional, Inc.

Reason for Recall

Super-Potent Drug: Out of specification potency results were obtained.

Advertisement
Recall Number
D-0290-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-03-07
Reported
2025-03-26
Distribution
Nationwide in the USA
Code Info
Lot 3116074, Exp. 09/30/2025
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement